These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10644353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9478-82. PubMed ID: 1719531
    [Abstract] [Full Text] [Related]

  • 5. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 6. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Münz C, Martin R.
    Brain; 2006 Jun 25; 129(Pt 6):1493-506. PubMed ID: 16569670
    [Abstract] [Full Text] [Related]

  • 7. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM, Wilkinson GW, Floettmann E, Blake N, Rickinson AB.
    J Virol; 1996 Apr 25; 70(4):2394-402. PubMed ID: 8642667
    [Abstract] [Full Text] [Related]

  • 8. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R, Burrows SR, Steigerwald-Mullen PM, Thomson SA, Kurilla MG, Moss DJ.
    Virology; 1995 Dec 20; 214(2):633-7. PubMed ID: 8553567
    [Abstract] [Full Text] [Related]

  • 9. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
    de Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG.
    J Exp Med; 1994 Apr 01; 179(4):1297-305. PubMed ID: 7511684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.
    Arthritis Res; 2000 Apr 01; 2(2):154-64. PubMed ID: 11062606
    [Abstract] [Full Text] [Related]

  • 15. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.
    Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM.
    Blood; 2001 Feb 15; 97(4):835-43. PubMed ID: 11159505
    [Abstract] [Full Text] [Related]

  • 16. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V, Höllsberg P.
    J Med Virol; 2004 Apr 15; 72(4):635-45. PubMed ID: 14981767
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
    Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB.
    Eur J Immunol; 1995 Jan 15; 25(1):102-10. PubMed ID: 7531142
    [Abstract] [Full Text] [Related]

  • 18. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.
    Bell MJ, Brennan R, Miles JJ, Moss DJ, Burrows JM, Burrows SR.
    J Infect Dis; 2008 Jun 01; 197(11):1594-7. PubMed ID: 18419576
    [Abstract] [Full Text] [Related]

  • 19. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ.
    J Exp Med; 1990 Jan 01; 171(1):345-9. PubMed ID: 1688611
    [Abstract] [Full Text] [Related]

  • 20. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR, Khanna R, Burrows JM, Moss DJ.
    J Exp Med; 1994 Apr 01; 179(4):1155-61. PubMed ID: 7511682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.